These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 9278608)

  • 41. Detection of Ebola virus in oral fluid specimens during outbreaks of Ebola virus hemorrhagic fever in the Republic of Congo.
    Formenty P; Leroy EM; Epelboin A; Libama F; Lenzi M; Sudeck H; Yaba P; Allarangar Y; Boumandouki P; Nkounkou VB; Drosten C; Grolla A; Feldmann H; Roth C
    Clin Infect Dis; 2006 Jun; 42(11):1521-6. PubMed ID: 16652308
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Ebola virus: what the practitioner needs to know].
    Georges AJ; Baize S; Leroy EM; Georges-Courbot MC
    Med Trop (Mars); 1998; 58(2):177-86. PubMed ID: 9791600
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Protective efficacy of neutralizing antibodies against Ebola virus infection.
    Takada A; Ebihara H; Jones S; Feldmann H; Kawaoka Y
    Vaccine; 2007 Jan; 25(6):993-9. PubMed ID: 17055127
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The pathology of experimental Ebola virus infection in monkeys.
    Baskerville A; Bowen ET; Platt GS; McArdell LB; Simpson DI
    J Pathol; 1978 Jul; 125(3):131-8. PubMed ID: 102747
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Development of a preventive vaccine for Ebola virus infection in primates.
    Sullivan NJ; Sanchez A; Rollin PE; Yang ZY; Nabel GJ
    Nature; 2000 Nov; 408(6812):605-9. PubMed ID: 11117750
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reverse genetic generation of recombinant Zaire Ebola viruses containing disrupted IRF-3 inhibitory domains results in attenuated virus growth in vitro and higher levels of IRF-3 activation without inhibiting viral transcription or replication.
    Hartman AL; Dover JE; Towner JS; Nichol ST
    J Virol; 2006 Jul; 80(13):6430-40. PubMed ID: 16775331
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fruit bats as reservoirs of Ebola virus.
    Leroy EM; Kumulungui B; Pourrut X; Rouquet P; Hassanin A; Yaba P; Délicat A; Paweska JT; Gonzalez JP; Swanepoel R
    Nature; 2005 Dec; 438(7068):575-6. PubMed ID: 16319873
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury.
    Yang ZY; Duckers HJ; Sullivan NJ; Sanchez A; Nabel EG; Nabel GJ
    Nat Med; 2000 Aug; 6(8):886-9. PubMed ID: 10932225
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ebola virus as a foodborne pathogen? Cause for consideration, but not panic.
    Bausch DG
    J Infect Dis; 2011 Jul; 204(2):179-81. PubMed ID: 21571727
    [No Abstract]   [Full Text] [Related]  

  • 50. Ebola virus infection in imported primates--United States.
    Can Dis Wkly Rep; 1990 Jan; 16(4):17-8. PubMed ID: 2302743
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Rapid and simple detection of Ebola virus by reverse transcription-loop-mediated isothermal amplification.
    Kurosaki Y; Takada A; Ebihara H; Grolla A; Kamo N; Feldmann H; Kawaoka Y; Yasuda J
    J Virol Methods; 2007 Apr; 141(1):78-83. PubMed ID: 17194485
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Towards a vaccine against Ebola virus.
    Geisbert TW; Jahrling PB
    Expert Rev Vaccines; 2003 Dec; 2(6):777-89. PubMed ID: 14711361
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Aerosol exposure to Zaire ebolavirus in three nonhuman primate species: differences in disease course and clinical pathology.
    Reed DS; Lackemeyer MG; Garza NL; Sullivan LJ; Nichols DK
    Microbes Infect; 2011 Oct; 13(11):930-6. PubMed ID: 21651988
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Ultrastructural stereological analysis of monkey lungs during experimental Ebola fever].
    Kolesnikova LV; Riabchikova EI; Rassadkin IuN; Grazhdantseva AA
    Biull Eksp Biol Med; 1997 Feb; 123(2):205-8. PubMed ID: 9280497
    [No Abstract]   [Full Text] [Related]  

  • 55. Clinical features and pathobiology of Ebolavirus infection.
    Ansari AA
    J Autoimmun; 2014 Dec; 55():1-9. PubMed ID: 25260583
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever.
    Bray M; Davis K; Geisbert T; Schmaljohn C; Huggins J
    J Infect Dis; 1999 Feb; 179 Suppl 1():S248-58. PubMed ID: 9988191
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Delayed Disease Progression in Cynomolgus Macaques Infected with Ebola Virus Makona Strain.
    Marzi A; Feldmann F; Hanley PW; Scott DP; Günther S; Feldmann H
    Emerg Infect Dis; 2015 Oct; 21(10):1777-83. PubMed ID: 26402165
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Laboratory diagnosis of Ebola and Marburg hemorrhagic fever.
    Grolla A; Lucht A; Dick D; Strong JE; Feldmann H
    Bull Soc Pathol Exot; 2005 Sep; 98(3):205-9. PubMed ID: 16267962
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Aerosol exposure to the angola strain of marburg virus causes lethal viral hemorrhagic Fever in cynomolgus macaques.
    Alves DA; Glynn AR; Steele KE; Lackemeyer MG; Garza NL; Buck JG; Mech C; Reed DS
    Vet Pathol; 2010 Sep; 47(5):831-51. PubMed ID: 20807825
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An introduction to Ebola: the virus and the disease.
    Peters CJ; LeDuc JW
    J Infect Dis; 1999 Feb; 179 Suppl 1():ix-xvi. PubMed ID: 9988154
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.